NASDAQ$PHVS

Pharvaris NV · Q1 2018 earnings

Q1 2018 earnings · · Investor relations

Headline financials

EPS (adj)

-€0.04

No prior period
Net Income

-€1.08M

No prior period
Operating Income

-€1.08M

No prior period
Gross Profit

€0.00

No prior period
R&D Expense

€911K

No prior period

Revenue & EPS history

Pharvaris · Revenue · Quarterly

€0

Q3 2025

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 13 quarterly earnings reports

Historical avg

+16.7%

Avg return

Earnings day

+16.1%

Avg return

5 days after

+27.4%

Avg return

30 days after

36%

5 / 14 earnings

Positive

+243.4%

Q3 2022

Best reaction

-10.4%

Q4 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.4%+1.5%+7.3%
Q3 2025+7.3%+3.3%+0.2%
Q4 2024-10.4%-9.2%+29.0%
Q3 2024+3.6%+5.4%-7.3%
Q4 2023-3.6%-12.9%-7.3%
Q3 2023+9.3%+2.7%+9.9%
Q2 2023-3.9%-1.4%+11.6%
Q4 2022-5.2%-2.0%+9.0%
Q3 2022+243.4%+241.4%+376.1%
Q2 2022-2.7%-2.1%-46.3%
Q4 2021-0.8%-0.4%-1.1%
Q3 2021-0.2%-0.8%-6.8%
Q2 2021-2.4%-1.8%+18.0%
Q1 2021+0.0%+1.2%-8.7%
Q3 2020
Q2 2020
Q1 2020
Q4 2019
Q3 2019
Q2 2019
Q1 2019
Q4 2018
Q3 2018
Q2 2018
Q1 2018

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro